Company

Bristol Myers Squibb

Investments

CompanyRoundDateLead
Ratio TherapeuticsSeries C2026-08-03
Dispatch BioSeries A2025-07-24
Be BioSeries C2025-01-15
Be BioFunding2024-10-23
Outpace BioSeries B Financing2024-08-01
Asher BioSeries C Funding2024-04-17Lead
TORL BioTherapeuticsSeries B-2 Funding2024-04-10
Capstan TherapeuticsSeries B Financing2024-03-21
Cour PharmaceuticalsSeries A2024-01-30
Accent TherapeuticsSeries C2024-01-23
CellaresSeries C Funding2023-08-23
TORL BioTherapeuticsSeries B Financing2023-04-13
Mediar TherapeuticsFunding2023-03-15
Cajal NeuroscienceSeries A2022-11-29